tiprankstipranks
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2315 full AI Analyst Report?

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Cash flow

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow

HK:2315's free cash flow for Q4 2025 was ¥110.72M. For the 2025 fiscal year, HK:2315's free cash flow was decreased by ¥108.31M and operating cash flow was ¥160.61M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
¥ 370.25M¥ 211.25M¥ -76.65M¥ -303.27M¥ -365.78M
Investing Cash Flow
¥ -184.86M¥ -137.12M¥ -100.28M¥ -153.74M¥ -84.13M
Financing Cash Flow
¥ 979.86M¥ -92.03M¥ -37.82M¥ 587.20M¥ 219.44M
End Cash Position
¥ 1.55B¥ 384.46M¥ 399.61M¥ 610.88M¥ 466.44M
Free Cash Flow
¥ 282.43M¥ 174.12M¥ -203.26M¥ -543.94M¥ -564.45M
Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow